Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
budesonide + arformoterol
- Development stage
- Phase 2
- Lead developer
- Korea United Pharm
- Modality
- Peptides, Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Inhalation
01
Overview
UI030 is an inhaled combination drug composed of budesonide and arformoterol, developed for the treatment of COVID-19. Budesonide is a corticosteroid with anti-inflammatory properties, while arformoterol is a long-acting beta2-adrenergic agonist (LABA) that acts as a bronchodilator. The combination aims to provide both antiviral and immune-modulating effects in patients with moderate to severe COVID-19. Developed by Korea United Pharm, UI030 has undergone phase 1 trials demonstrating safety and inhalation efficiency, and entered phase 2 clinical trials in South Korea for efficacy and safety evaluation in COVID-19 patients. The product is designed as an at-home self-treatment option delivered via inhaler[3].
- Other names
- UI030UI-030UI 030
02
Targets
GR (Glucocorticoid receptor)ADRB2 (β2)
Beyond the preview
Go deeper on budesonide + arformoterol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on budesonide + arformoterol.